GALNT10 and cholangiocarcinoma: The long noncoding RNA DLGAP1‐AS2 facilitates the malignant progression of cholangiocarcinoma via miR‐505 and GALNT10 and may have potential as a novel target for cholangiocarcinoma therapy.